|
End-of-day quote
Shanghai S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 5.060 CNY | -0.59% |
|
+2.22% | -1.17% |
| 29/07 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 16/07 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| Market Cap | 25.23B 3.74B 3.23B 3.04B 2.76B 5.19B 358B 5.28B 35.58B 13.91B 179B 14.05B 13.74B 595B | P/E 2026 * |
10.9x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 20.91B 3.1B 2.68B 2.52B 2.29B 4.3B 296B 4.37B 29.48B 11.53B 148B 11.64B 11.39B 493B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.13% | Yield 2027 * | 4.4% |
| 1 day | -0.59% | ||
| 1 week | +2.22% | ||
| Current month | -1.75% | ||
| 3 months | -0.20% | ||
| 6 months | -1.75% | ||
| Current year | -1.17% |
| 1 week | 4.93 |  | 5.17 |
| 1 month | 4.87 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 15/10/2024 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 15/11/2023 |
Wei He
CEO | Chief Executive Officer | 40 | 23/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 16/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 05/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 01/07/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/24 | Buy | Chief Executive Officer | 60,494 | 0.0015% | ||
| 7/6/24 | Buy | 3,025 | 0.0001% | |||
| 7/6/24 | Buy | Director | 1,210 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59% | +2.22% | -6.12% | -4.61% | 3.76B | |
| +0.95% | -0.64% | +28.23% | +97.26% | 99.88B | |
| +0.62% | -1.64% | +54.79% | +150.06% | 53.78B | |
| 0.00% | -0.33% | +4.20% | +272.50% | 24.2B | |
| -1.13% | +0.97% | -12.64% | -13.95% | 8.32B | |
| +0.54% | +6.83% | -31.49% | -24.63% | 7.69B | |
| -0.24% | -2.34% | -13.61% | -22.51% | 6.66B | |
| +1.24% | +2.26% | +9.25% | +19.91% | 6.23B | |
| +0.31% | -1.34% | -6.08% | +19.44% | 4.96B | |
| +0.39% | +0.95% | +6.92% | +15.20% | 3.62B | |
| Average | +0.28% | -0.89% | +3.35% | +50.87% | 21.91B | |
| Weighted average by Cap. | +0.62% | -1.59% | +24.92% | +110.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.18B 21.74B 20.43B 18.58B 34.94B 2,407B 35.51B 239B 93.61B 1,205B 94.52B 92.47B 4,006B | 178B 26.45B 22.84B 21.47B 19.52B 36.7B 2,529B 37.31B 252B 98.34B 1,266B 99.3B 97.14B 4,209B |
| Net income | 2.33B 345M 298M 280M 255M 479M 33.02B 487M 3.28B 1.28B 16.53B 1.3B 1.27B 54.95B | 2.52B 373M 322M 303M 275M 518M 35.69B 526M 3.55B 1.39B 17.87B 1.4B 1.37B 59.39B |
| Net Debt | -4.32B -641M -553M -520M -473M -889M -61.26B -904M -6.09B -2.38B -30.68B -2.41B -2.35B -102B | -5.04B -748M -646M -607M -552M -1.04B -71.5B -1.05B -7.11B -2.78B -35.8B -2.81B -2.75B -119B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | CNY 5.060 | -0.59% | 26,936,680 |
| 13/08/26 | CNY 5.090 | +0.99% | 45,553,731 |
| 12/08/26 | CNY 5.040 | -0.59% | 43,655,619 |
| 11/08/26 | CNY 5.070 | +0.40% | 43,661,675 |
| 10/08/26 | CNY 5.050 | +1.20% | 45,445,440 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
